Skip to main content
Premium Trial:

Request an Annual Quote

Two Additional Lawsuits Filed Seeking to Block BGI Buy of Complete Genomics

NEW YORK (GenomeWeb News) – Two additional lawsuits have been filed seeking to block BGI's $117.6 million purchase of Complete Genomics.

In documents filed with the US Securities and Exchange Commission on Tuesday, Complete Genomics disclosed the two new lawsuits, which follow two earlier lawsuits also seeking to stop the sale of the company to BGI.

One lawsuit, Chad Gerber v. Clifford A. Reid, et al, was filed on Sept. 28 in the Delaware court of Chancery. Another lawsuit, Saba Saleemi v. Complete Genomics, Inc., et al, was filed on Oct. 1 also in the Delaware Court of Chancery.

In addition to Complete Genomics, its directors and BGI are named as defendants in both cases, which allege breach of fiduciary duties. Both lawsuits seek, among other things, a preliminary and permanent injunction against the deal. They also seek class action status.

Complete Genomics and BGI said at the time it was announced that the acquisition is expected to be completed in early 2013.

In Wednesday afternoon trading on the Nasdaq, Complete Genomics' shares were flat at $3.10.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.